{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:26:42Z","timestamp":1773415602320,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10384-023-01010-w","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T02:01:36Z","timestamp":1689472896000},"page":"565-569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of azithromycin hydrate ophthalmic solution for treatment of internal hordeolum and meibomitis with or without phlyctenular keratitis"],"prefix":"10.1007","volume":"67","author":[{"given":"Yurie","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Shinji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Mitoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4001-678X","authenticated-orcid":false,"given":"Taiichiro","family":"Chikama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,16]]},"reference":[{"key":"1010_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","volume":"89","author":"JP McCulley","year":"1982","unstructured":"McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173\u201380.","journal-title":"Ophthalmology"},{"key":"1010_CR2","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","volume":"52","author":"KK Nichols","year":"2011","unstructured":"Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: Executive summary. Investig Ophthalmol Vis Sci. 2011;52:1922\u20139.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"1010_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0002-9394(77)90497-4","volume":"84","author":"JP McCulley","year":"1977","unstructured":"McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788\u201393.","journal-title":"Am J Ophthalmol"},{"key":"1010_CR4","doi-asserted-by":"publisher","first-page":"DES94","DOI":"10.1167\/iovs.17-23345","volume":"59","author":"T Suzuki","year":"2018","unstructured":"Suzuki T. Inflamed obstructive meibomian gland dysfunction causes ocular surface inflammation. Investig Opthalmology Vis Sci. 2018;59:DES94.","journal-title":"Investig Opthalmology Vis Sci"},{"key":"1010_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jtos.2014.12.002","volume":"13","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Teramukai S, Kinoshita S. Meibomian glands and ocular surface inflammation. Ocul Surf. 2015;13:133\u201349.","journal-title":"Ocul Surf"},{"key":"1010_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/jop.2009.0026","volume":"25","author":"EK Akpek","year":"2009","unstructured":"Akpek EK, Vittitow J, Verhoeven RS, Brubaker K, Amar T, Powell KD, et al. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation. J Ocul Pharmacol Ther. 2009;25:433\u20139.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1010_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2147\/OPTH.S6370","volume":"4","author":"J Luchs","year":"2010","unstructured":"Luchs J. Azithromycin in durasite\u00ae for the treatment of blepharitis. Clin Ophthalmol. 2010;4:681\u20138.","journal-title":"Clin Ophthalmol"},{"key":"1010_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/ICO.0b013e3181cda38f","volume":"29","author":"GN Foulks","year":"2010","unstructured":"Foulks GN, Borchman D, Yappert M, Kim S-H, McKay JW. Topical azithromycin therapy for Meibomian Gland Dysfunction: clinical response and lipid alterations. Cornea. 2010;29:781\u20138.","journal-title":"Cornea"},{"key":"1010_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/ICL.0000000000000729","volume":"47","author":"R Arita","year":"2021","unstructured":"Arita R, Fukuoka S. Efficacy of azithromycin eyedrops for individuals with Meibomian Gland Dysfunction-Associated posterior blepharitis. Eye Contact Lens. 2021;47:54\u20139.","journal-title":"Eye Contact Lens"},{"key":"1010_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10384-022-00947-8","volume":"66","author":"R Nejima","year":"2022","unstructured":"Nejima R, Eguchi H, Todokoro D, Inoue T, Kaji Y, Suzuki T, et al. Analysis of treatment protocols using azithromycin eye drops for bacterial blepharitis: second report\u2014bacteriological investigation. Jpn J Ophthalmol. 2022;66:579\u201389.","journal-title":"Jpn J Ophthalmol"},{"key":"1010_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/ICO.0b013e3181ca38a0","volume":"29","author":"RM Haque","year":"2010","unstructured":"Haque RM, Torkildsen GL, Brubaker K, Zink RC, Kowalski RP, Mah FS, et al. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea. 2010;29:871\u20137.","journal-title":"Cornea"},{"key":"1010_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/ICO.0000000000002233","volume":"39","author":"E Ciloglu","year":"2020","unstructured":"Ciloglu E, \u00d6zcan AA, Incekalan T, Unal F. The role of topical azithromycin in the treatment of Meibomian Gland Dysfunction. Cornea. 2020;39:321\u20134.","journal-title":"Cornea"},{"key":"1010_CR13","first-page":"101042","volume":"66","author":"AA Gordon","year":"2020","unstructured":"Gordon AA, Danek DJ, Phelps PO. Common inflammatory and infectious conditions of the eyelid. DisMon. 2020;66:101042.","journal-title":"DisMon."},{"key":"1010_CR14","unstructured":"Japanese Association for Ocular Infection: Guidelines for the Clinical Trials of Topical Ophthalmic Antibacterial Agent. Ministry of Health, Labour and Welfare.\u00a0(in Japanese).\u00a0Accessed 18 Apr 2023."},{"key":"1010_CR15","doi-asserted-by":"publisher","first-page":"251584141878362","DOI":"10.1177\/2515841418783622","volume":"10","author":"KA Kagkelaris","year":"2018","unstructured":"Kagkelaris KA, Makri OE, Georgakopoulos CD, Panayiotakopoulos GD. An eye for azithromycin: review of the literature. Ther Adv Ophthalmol. 2018;10:251584141878362.","journal-title":"Ther Adv Ophthalmol"},{"key":"1010_CR16","unstructured":"Azimycin ophthalmic solution 1%. Package insert. Senju Pharmaceutical Co., Ltd; 2020. (in Japanese)."},{"key":"1010_CR17","first-page":"297","volume":"6","author":"P Hirunwiwatkul","year":"2012","unstructured":"Hirunwiwatkul P, Wachirasereechai K, Khantipong M, Chongthaleong A. Identifications of hordeolum pathogens and its susceptibility to antimicrobial agents in topical and oral medications. Asian Biomed. 2012;6:297\u2013302.","journal-title":"Asian Biomed"},{"key":"1010_CR18","first-page":"1","volume":"61","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Sutani T, Nakai H, Shirahige K, Kinoshita S. The microbiome of the meibum and ocular surface in healthy subjects. Investig Ophthalmol Vis Sci. 2020;61:1\u20137.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1010_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/00003226-200211000-00017","volume":"21","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Sano Y, Sasaki O, Kinoshita S. Ocular surface inflammation induced by Propionibacterium acnes. Cornea. 2002;21:812\u20137.","journal-title":"Cornea"},{"key":"1010_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/ICO.0b013e31826a04dd","volume":"31","author":"T Suzuki","year":"2012","unstructured":"Suzuki T. Meibomitis-Related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation. Cornea. 2012;31:41\u20134.","journal-title":"Cornea"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-023-01010-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-023-01010-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-023-01010-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T01:04:59Z","timestamp":1693443899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-023-01010-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1007\/s10384-023-01010-w","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,16]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Shimizu, None; K. Shinji, None; K. Mitoma, None; Y. Kiuchi, None; T. Chikama, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}